BPC-157, Thymosin Alpha-1, and TB4: What the Science Actually Says About the Peptides the FDA Banned

19 Jun 2026 · 20 min
19:50

In this 2026 YouTube presentation, Dr. Aaron Hartman reviews several peptides that have been popular in functional‑medicine and anti‑aging circles but have faced increasing FDA restrictions after 2023. He begins with a brief call to subscribe, then systematically discusses each peptide’s discovery, biological mechanism, clinical applications, evidence base, safety profile, regulatory status, and practical considerations such as sourcing, dosing, and patient selection. Thymosin α‑1 – discovered in the 1970s, enhances T‑cell maturation, NK‑cell activity, and cytokine balance; approved in >35 countries for hepatitis B/C, cancer support, and immune modulation, but not FDA‑approved in the US due to lack of commercial sponsorship. Over 11,000 human subjects have been studied. FDA re‑classified it from Category 1 to Category 2 in 2020, effectively banning compounding pharmacies. Quality concerns arise from research‑grade imports, especially from China. Thymosin β‑4 / TB‑500 – a 17‑amino‑acid fragment of the full β‑4 peptide, discovered by the same group; regulates protein synthesis, cell migration, and tissue repair; used for musculoskeletal injuries, scar reduction, and pulmonary/renal fibrosis via TGF‑β1 modulation. Animal data are strong; a Phase 2 trial (2009) remains unpublished, highlighting publication bias. BPC‑157 – a 15‑amino‑acid peptide isolated from human gastric juice in the 1990s; promotes angiogenesis, nitric‑oxide modulation, growth‑hormone interaction, and barrier repair (gut, blood‑brain). Over 100 pre‑clinical studies and a 2025 systematic review of 544 papers; only one human intra‑articular knee trial. Considered GRAS and sold as a supplement, yet compounding pharmacies cannot legally produce it. Oral formulations lose potency compared with injectable routes. CJC‑1295 + Ipamorelin stack – synthetic GHRH analog (CJC‑1295) combined with a ghrelin‑mimetic (Ipamorelin) to stimulate pulsatile growth‑hormone release while limiting excessive, sustained elevations that could raise cancer risk. Discusses DAC (drug‑affinity‑complex) variants with 7‑day half‑life that may oversaturate receptors. Highlights benefits for tissue healing, sleep quality, and age‑related GH decline, while warning against high‑dose, long‑acting formulations. GHK‑Cu – a tripeptide‑copper complex discovered in the 1970s; stimulates collagen, glycosaminoglycans, nerve growth, and possibly normalizes tumor‑cell gene expression. Used topically in aesthetic medicine for skin rejuvenation, wound healing, and hair regrowth. Remains Category 1 (not banned). Overall peptide landscape & clinical integration – >7,000 known peptides, ~70‑80 synthetically accessible. Dr. Hartman stresses foundational health (nutrition, toxin removal, sleep) before peptide therapy, especially for patients >40 y. He advises against routine peptide use in teens/early‑20s, recommending investigation of underlying deficiencies first. The talk blends historical context, mechanistic insight, regulatory commentary, and pragmatic guidance for clinicians considering peptide therapy.

Chapters

More from Aaron

53:04
youtube.com

Too Many Gut Fixes Can Undo Your Healing. What Helps It Last | Dr. Sabine Hazan

4d ago
6:54
youtube.com

Sometimes I Treat It Before I Know What Caused It

1w ago
45:33
youtube.com

Your Gut Keeps Its Own Age, and It Can Get Younger

1w ago
6:53
youtube.com

Lyme Is Supposed to Be Diagnosed Without a Blood Test

2w ago
1:18
youtube.com

Women’s Heart Attack Symptoms Differ From Men’s 95% of the Time — Only 30% Have Chest Pain #shorts

2w ago
1:42
youtube.com

Heart Disease Kills More Women Than All Cancers Combined — 80% of Cardiac Research Is on Men #shorts

2w ago
2:03
youtube.com

Women’s Physiology Was Systematically Ignored in Drug Research — The Consequences Are Still #shorts

2w ago
1:03:14
youtube.com

Why Cancer Comes Back Somewhere Else with Dr. Nasha Winters

2w ago
7:10
youtube.com

How Mold Became Too Common to Take Seriously

3w ago
2:37
youtube.com

It Took the FDA 20 Years to Realize Women Need Half the Dose of Ambien #shorts

3w ago
1:32
youtube.com

Until 1993, Women Were Banned From Clinical Drug Trials — Then Those Drugs Were Prescribed t #shorts

3w ago
See all content